COVID-19 The pandemic continues to cause unprecedented disruption across industries worldwide. Get detailed insights regarding the impact of COVID-19 on the market.
Europe Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
The Europe generic drug market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to continue its strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Generic drugs are pharmaceutical drugs with an equivalent therapeutic effect as their branded counterparts. These drugs are also identical to the innovator drug in terms of safety, strength, quality, dosage route of administration and intended usage. Unlike branded drugs, generic drugs are cost-efficient and they do not require hefty investments in marketing campaigns or clinical studies.
Governments of various countries in Europe, along with healthcare authorities, are presently concerned about inflating pharmaceutical prices. As a result, they are increasingly promoting the usage of generic drugs over their branded counterparts, which represents one of the significant factors propelling the growth of the market. Apart from this, low production costs of generic drugs are attracting manufacturers to make capital investments in the industry. Moreover, the rising utilization of 3D printing technology in the healthcare sector is resulting in the increasing launch of generic drugs with customized sizes, forms and textures. Furthermore, the high prevalence of chronic diseases in the region is propelling governing agencies to finance research and development (R&D) for launching new compounds and improving existing technologies.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe generic drug market, along with forecasts at the regional and country level from 2021-2026. Our report has categorized the market based on segment, therapy area, drug delivery and distribution channel.
Breakup by Segment:
Unbranded Generics
Branded Generics
Breakup by Therapy Area:
Central Nervous System
Cardiovascular
Dermatology
Genitourinary/Hormonal
Respiratory
Rheumatology
Diabetes
Oncology
Others
Breakup by Drug Delivery:
Oral
Injectables
Dermal/Topical
Inhalers
Breakup by Distribution Channel:
Retail
Hospital
Breakup by Country:
Germany
France
United Kingdom
Italy
Spain
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
Report Features
Details
Base Year of the Analysis
2020
Historical Period
2015-2020
Forecast Period
2021-2026
Units
US$ Million
Segment Coverage
Segment, Therapy Area, Drug Delivery, Distribution Channel, Country
Countries Covered
Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope
10% Free Customization
Report Price and Purchase Option
Post-Sale Analyst Support
10-12 Weeks
Delivery Format
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
How has the Europe generic drug market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Europe generic drug market?
What are the key regional markets?
What is the breakup of the market based on the segment?
What is the breakup of the market based on the therapy area?
What is the breakup of the market based on the drug delivery?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the Europe generic drug market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology 3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends 5 Europe Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast 6 Market Breakup by Segment
6.1 Unbranded Generics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Branded Generics
6.2.1 Market Trends
6.2.2 Market Forecast 7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast 8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast 9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast 10 Market Breakup by Country
10.1 Germany
10.1.1 Market Trends
10.1.2 Market Breakup by Segment
10.1.3 Market Breakup by Therapy Area
10.1.4 Market Breakup by Drug Delivery
10.1.5 Market Breakup by Distribution Channel
10.1.6 Market Forecast
10.2 France
10.2.1 Market Trends
10.2.2 Market Breakup by Segment
10.2.3 Market Breakup by Therapy Area
10.2.4 Market Breakup by Drug Delivery
10.2.5 Market Breakup by Distribution Channel
10.2.6 Market Forecast
10.3 United Kingdom
10.3.1 Market Trends
10.3.2 Market Breakup by Segment
10.3.3 Market Breakup by Therapy Area
10.3.4 Market Breakup by Drug Delivery
10.3.5 Market Breakup by Distribution Channel
10.3.6 Market Forecast
10.4 Italy
10.4.1 Market Trends
10.4.2 Market Breakup by Segment
10.4.3 Market Breakup by Therapy Area
10.4.4 Market Breakup by Drug Delivery
10.4.5 Market Breakup by Distribution Channel
10.4.6 Market Forecast
10.5 Spain
10.5.1 Market Trends
10.5.2 Market Breakup by Segment
10.5.3 Market Breakup by Therapy Area
10.5.4 Market Breakup by Drug Delivery
10.5.5 Market Breakup by Distribution Channel
10.5.6 Market Forecast
10.6 Others
10.6.1 Market Trends
10.6.2 Market Breakup by Segment
10.6.3 Market Breakup by Therapy Area
10.6.4 Market Breakup by Drug Delivery
10.6.5 Market Breakup by Distribution Channel
10.6.6 Market Forecast 11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats 12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes 14 Price Analysis
15 Policy and Regulatory Landscape
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
List of Figures
Figure 1: Europe: Generic Drug Market: Major Drivers and Challenges
Figure 2: Europe: Generic Drug Market: Sales Value (in Million US$), 2015-2020
Figure 3: Europe: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Europe: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 5: Europe: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 6: Europe: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 7: Europe: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 8: Europe: Generic Drug Market: Breakup by Country (in %), 2020
Figure 9: Europe: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Europe: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Europe: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Europe: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Europe: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Europe: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Europe: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Europe: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Europe: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Europe: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Europe: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Europe: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Europe: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Europe: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Europe: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Europe: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Europe: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Europe: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Europe: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Europe: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Europe: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Europe: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Europe: Generic Drug (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Europe: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Europe: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Europe: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Europe: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Europe: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Europe: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Europe: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Europe: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Europe: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Europe: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Europe: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Germany: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Germany: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 45: Germany: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 46: Germany: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 47: Germany: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 48: Germany: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: France: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: France: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 51: France: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 52: France: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 53: France: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 54: France: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: United Kingdom: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: United Kingdom: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 57: United Kingdom: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 58: United Kingdom: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 59: United Kingdom: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 60: United Kingdom: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Italy: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Italy: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 63: Italy: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 64: Italy: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 65: Italy: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 66: Italy: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Spain: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Spain: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 69: Spain: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 70: Spain: Generic Drug Market: Breakup by Drug Channel (in %), 2020
Figure 71: Spain: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 72: Spain: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Europe Generic Drug Industry: SWOT Analysis
Figure 76: Europe: Generic Drug Industry: Value Chain Analysis
Figure 77: Europe: Generic Drug Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Europe: Generic Drug Market: Key Industry Highlights, 2020 and 2026
Table 2: Europe: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2021-2026
Table 3: Europe: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2021-2026
Table 4: Europe: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2021-2026
Table 5: Europe: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Europe: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 7: Europe: Generic Drug Market: Competitive Structure
Table 8: Europe: Generic Drug Market: Key Players
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
All content published on the Site including text, designs, logos, graphics, data, materials, etc. (“Content”) are the sole property of IMARC Group or their respective licensors and are protected by the regional and international copyright laws. Learn More
This site uses cookies (including third-party cookies) to record user’s preferences which help us to
enhance our services. For further information review our Privacy Policy.
